Ariana Gross
Adult Health · Palm Coast, FLNPI 1184988321
Payments from drug & device makers
Across 100 payments — averaging $50.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$976
- Johnson & Johnson$635
- AbbVie$376
- Novo Nordisk$342
- Bayer$224
- Sanofi$157
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,017100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 16 | $976 |
| Johnson & Johnson(2 entities) | 13 | $635 |
| AbbVie | 5 | $376 |
| Novo Nordisk | 3 | $342 |
| Bayer | 2 | $224 |
| Sanofi | 5 | $157 |
| Solventum Corporation | 2 | $154 |
| E.r. Squibb & Sons, L.L.C. | 1 | $121 |
| Pfizer | 1 | $121 |
| Inari Medical, Inc. | 1 | $106 |
| Incyte Corporation | 6 | $105 |
| Silk Road Medical, Inc. | 1 | $104 |
| Merck | 3 | $103 |
| Mallinckrodt Hospital Products Inc. | 1 | $103 |
| Vantive US Healthcare LLC | 1 | $101 |
| Daiichi Sankyo Inc. | 4 | $99 |
| Esperion Therapeutics, Inc. | 1 | $96 |
| Boston Scientific | 1 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $90 |
| Sobi, Inc | 1 | $85 |
| Caris MPI, Inc. | 2 | $79 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $78 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $76 |
| Sanofi-aventis U.S. LLC | 1 | $70 |
| Lilly USA, LLC | 3 | $69 |
| Avanos Medical | 1 | $65 |
| Eisai Inc. | 3 | $59 |
| Philips North America LLC | 1 | $58 |
| Genentech USA, Inc. | 3 | $57 |
| Novartis | 3 | $55 |
| Stemline Therapeutics Inc. | 3 | $50 |
| Exelixis Inc. | 1 | $22 |
| Array Biopharma Inc | 1 | $22 |
| Springworks Therapeutics, Inc. | 1 | $21 |
| Recordati_rare_diseases_inc. | 1 | $18 |
| GSK | 1 | $17 |
| Puma Biotechnology, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Strensiq$267
- Kerendia$224
- XARELTO$220
- ENROUTE Transcarotid Neuroprotection System$207
- DALVANCE$125
- EMBLAVEO$124
- Enhertu$121
- PADCEV$121
- RYBREVANT$120
- CARVYKTI$120
- V.A.C. VERAFLO$114
- FLOWTRIEVER CATHETER, S$106
- CT THROMBECTOMY SYSTEM KIT$106
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$104
- ENROUTE Transcarotid Stent$104
- TERLIVAZ$103
- Wegovy$101
- Renal - Acute$101
How this compares
$5,017 in reported general payments places this provider in the 90th percentile of 2,237 adult health providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other adult health in Palm Coast
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Alejandro Dela CruzOrlando$44K
- Cynthia OteroMaitland$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.